“Appendix 3B New issue announcement, application for quotation of additional securities and agreement” has been released by Imagion Biosystems. Read Appendix 3B here.
Imagion Appoints New Non-Executive Director, Brett Mitchell
MELBOURNE – Imagion Biosystems (ASX:IBX), a company dedicated to improving healthcare through the early detection of cancer, today announced the appointment of Mr Brett Mitchell